|
1
|
Lim CY, Ng GWY, Goh CK, Lee MKC, Cheong I,
Ooi EE, Liu J, West RB, Loh KS and Tay JK: Impact of high-risk EBV
strains on nasopharyngeal carcinoma gene expression. Oral Oncol.
157:1069412024. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yip PL, Lee AWM and Chua MLK: Adjuvant
chemotherapy in nasopharyngeal carcinoma. Lancet Oncol. 24:713–715.
2023. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Dixon SJ, Lemberg KM, Lamprecht MR, Skouta
R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS,
et al: Ferroptosis: An iron-dependent form of nonapoptotic cell
death. Cell. 149:1060–1072. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lee S, Hwang N, Seok BG, Lee S, Lee SJ and
Chung SW: Autophagy mediates an amplification loop during
ferroptosis. Cell Death Dis. 14:4642023. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kinowaki Y, Taguchi T, Onishi I, Kirimura
S, Kitagawa M and Yamamoto K: Overview of ferroptosis and synthetic
lethality strategies. Int J Mol Sci. 22:92712021. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Alborzinia H, Chen Z, Yildiz U, Freitas
FP, Vogel FCE, Varga JP, Batani J, Bartenhagen C, Schmitz W, Büchel
G, et al: LRP8-mediated selenocysteine uptake is a targetable
vulnerability in MYCN-amplified neuroblastoma. EMBO Mol Med.
15:e180142023. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Floros KV, Cai J, Jacob S, Kurupi R,
Fairchild CK, Shende M, Coon CM, Powell KM, Belvin BR, Hu B, et al:
MYCN-amplified neuroblastoma is addicted to iron and vulnerable to
inhibition of the system Xc-/glutathione axis. Cancer Res.
81:1896–1908. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lu Y, Yang Q, Su Y, Ji Y, Li G, Yang X, Xu
L, Lu Z, Dong J, Wu Y, et al: MYCN mediates TFRC-dependent
ferroptosis and reveals vulnerabilities in neuroblastoma. Cell
Death Dis. 12:5112021. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lei G, Zhuang L and Gan B: Targeting
ferroptosis as a vulnerability in cancer. Nat Rev Cancer.
22:381–396. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhou J, Guo T, Zhou L, Bao M, Wang L, Zhou
W, Tan S, Li G, He B and Guo Z: The ferroptosis signature predicts
the prognosis and immune microenvironment of nasopharyngeal
carcinoma. Sci Rep. 13:18612023. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Teng Y, Gao L, Mäkitie AA, Florek E,
Czarnywojtek A, Saba NF and Ferlito A: Iron, ferroptosis, and head
and neck cancer. Int J Mol Sci. 24:151272023. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mao C, Wang M, Zhuang L and Gan B:
Metabolic cell death in cancer: Ferroptosis, cuproptosis,
disulfidptosis, and beyond. Protein Cell. 15:642–660. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Luo T, Wang Y and Wang J: Ferroptosis
assassinates tumor. J Nanobiotechnology. 20:4672022. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xu Y, Wang Q, Li X, Chen Y and Xu G:
Itraconazole attenuates the stemness of nasopharyngeal carcinoma
cells via triggering ferroptosis. Environ Toxicol. 36:257–266.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li Y, Du Y, Zhou Y, Chen Q, Luo Z, Ren Y,
Chen X and Chen G: Iron and copper: critical executioners of
ferroptosis, cuproptosis and other forms of cell death. Cell Commun
Signal. 21:3272023. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hadian K and Stockwell BR: SnapShot:
Ferroptosis. Cell. 181:1188–1188.e1. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ma TL, Chen JX, Zhu P, Zhang CB, Zhou Y
and Duan JX: Focus on ferroptosis regulation: Exploring novel
mechanisms and applications of ferroptosis regulator. Life Sci.
307:1208682022. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gan B: Mitochondrial regulation of
ferroptosis. J Cell Biol. 220:e2021050432021. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen Y, Guo X, Zeng Y, Mo X, Hong S, He H,
Li J, Fatima S and Liu Q: Oxidative stress induces mitochondrial
iron overload and ferroptotic cell death. Sci Rep. 13:155152023.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wahida A and Conrad M: Ferroptosis: Under
pressure! Curr Biol. 33:R269–R272. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lai L, Tan M, Hu M, Yue X, Tao L, Zhai Y
and Li Y: Important molecular mechanisms in ferroptosis. Mol Cell
Biochem. 480:639–658. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang XD, Liu ZY, Wang MS, Guo YX, Wang
XK, Luo K, Huang S and Li RF: Mechanisms and regulations of
ferroptosis. Front Immunol. 14:12694512023. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zheng J and Conrad M: The metabolic
underpinnings of ferroptosis. Cell Metab. 32:920–937. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang Z, Lu M, Chen C, Tong X, Li Y, Yang
K, Lv H, Xu J and Qin L: Holo-lactoferrin: the link between
ferroptosis and radiotherapy in triple-negative breast cancer.
Theranostics. 11:3167–3182. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu J, Kang R and Tang D: Signaling
pathways and defense mechanisms of ferroptosis. FEBS J.
289:7038–7050. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chen X, Li J, Kang R, Klionsky DJ and Tang
D: Ferroptosis: Machinery and regulation. Autophagy. 17:2054–2081.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Seibt T, Wahida A, Hoeft K, Kemmner S,
Linkermann A, Mishima E and Conrad M: The biology of ferroptosis in
kidney disease. Nephrol Dial Transplant. 39:1754–1761. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Dutt S, Hamza I and Bartnikas TB:
Molecular mechanisms of iron and heme metabolism. Annu Rev Nutr.
42:311–335. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhao Y, Yang M and Liang X: The role of
mitochondria in iron overload-induced damage. J Transl Med.
22:10572024. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang H, Zhang Z, Ruan S, Yan Q, Chen Y,
Cui J, Wang X, Huang S and Hou B: Regulation of iron metabolism and
ferroptosis in cancer stem cells. Front Oncol. 13:12515612023.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Li S, Zhang G, Hu J, Tian Y and Fu X:
Ferroptosis at the nexus of metabolism and metabolic diseases.
Theranostics. 14:5826–5852. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Venkataramani V: Iron homeostasis and
metabolism: Two sides of a coin. Adv Exp Med Biol. 1301:25–40.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Huang L, Bian M, Zhang J and Jiang L: Iron
metabolism and ferroptosis in peripheral nerve injury. Oxid Med
Cell Longev. 2022:59182182022. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Capelletti MM, Manceau H, Puy H and Peoc'h
K: Ferroptosis in liver diseases: An Overview. Int J Mol Sci.
21:49082020. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wu L, Xian X, Tan Z, Dong F, Xu G, Zhang M
and Zhang F: The role of iron metabolism, lipid metabolism, and
redox homeostasis in Alzheimer's disease: From the perspective of
ferroptosis. Mol Neurobiol. 60:2832–2850. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lyamzaev KG, Panteleeva AA, Simonyan RA,
Avetisyan AV and Chernyak BV: Mitochondrial lipid peroxidation is
responsible for ferroptosis. Cells. 12:6112023. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Do Q and Xu L: How do different lipid
peroxidation mechanisms contribute to ferroptosis? Cell Rep Phys
Sci. 4:1016832023. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Naowarojna N, Wu TW, Pan Z, Li M, Han JR
and Zou Y: Dynamic regulation of ferroptosis by lipid metabolism.
Antioxid Redox Signal. 39:59–78. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Xin S and Schick JA: PUFAs dictate the
balance of power in ferroptosis. Cell Calcium. 110:1027032023.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Cui S, Simmons G Jr, Vale G, Deng Y, Kim
J, Kim H, Zhang R, McDonald JG and Ye J: FAF1 blocks ferroptosis by
inhibiting peroxidation of polyunsaturated fatty acids. Proc Natl
Acad Sci USA. 119:e21071891192022. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Qiu B, Zandkarimi F, Bezjian CT, Reznik E,
Soni RK, Gu W, Jiang X and Stockwell BR: Phospholipids with two
polyunsaturated fatty acyl tails promote ferroptosis. Cell.
187:1177–1190.e18. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Ma XH, Liu JH, Liu CY, Sun WY, Duan WJ,
Wang G, Kurihara H, He RR, Li YF, Chen Y and Shang H:
ALOX15-launched PUFA-phospholipids peroxidation increases the
susceptibility of ferroptosis in ischemia-induced myocardial
damage. Signal Transduct Target Ther. 7:2882022. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Do Q, Zhang R, Hooper G and Xu L:
Differential contributions of distinct free radical peroxidation
mechanisms to the induction of ferroptosis. JACS Au. 3:1100–1117.
2023. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Li Y, Li Z, Ran Q and Wang P: Sterols in
ferroptosis: From molecular mechanisms to therapeutic strategies.
Trends Mol Med. 31:36–49. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Gan B: ACSL4, PUFA, and ferroptosis: New
arsenal in anti-tumor immunity. Signal Transduct Target Ther.
7:1282022. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Sokol KH, Lee CJ, Rogers TJ, Waldhart A,
Ellis AE, Madireddy S, Daniels SR, House RRJ, Ye X, Olesnavich M,
et al: Lipid availability influences ferroptosis sensitivity in
cancer cells by regulating polyunsaturated fatty acid trafficking.
Cell Chem Biol. 32:408–422.e6. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Hirata Y, Ferreri C, Yamada Y, Inoue A,
Sansone A, Vetica F, Suzuki W, Takano S, Noguchi T, Matsuzawa A and
Chatgilialoglu C: Geometrical isomerization of arachidonic acid
during lipid peroxidation interferes with ferroptosis. Free Radic
Biol Med. 204:374–384. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Liu S, Zhang HL, Li J, Ye ZP, Du T, Li LC,
Guo YQ, Yang D, Li ZL, Cao JH, et al: Tubastatin A potently
inhibits GPX4 activity to potentiate cancer radiotherapy through
boosting ferroptosis. Redox Biol. 62:1026772023. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Nishida Xavier da Silva T, Friedmann
Angeli JP and Ingold I: GPX4: Old lessons, new features. Biochem
Soc Trans. 50:1205–1213. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Chen T, Leng J, Tan J, Zhao Y, Xie S, Zhao
S, Yan X, Zhu L, Luo J, Kong L and Yin Y: Discovery of novel potent
covalent glutathione peroxidase 4 inhibitors as highly selective
ferroptosis inducers for the treatment of triple-negative breast
cancer. J Med Chem. 66:10036–10059. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Rochette L, Dogon G, Rigal E, Zeller M,
Cottin Y and Vergely C: Lipid peroxidation and iron metabolism: Two
corner stones in the homeostasis control of ferroptosis. Int J Mol
Sci. 24:4492022. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Guo W, Li K, Sun B, Xu D, Tong L, Yin H,
Liao Y, Song H, Wang T, Jing B, et al: Dysregulated glutamate
transporter SLC1A1 propels cystine uptake via Xc− for
glutathione synthesis in lung cancer. Cancer Res. 81:552–566. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Li Z, Li Y, Yang Y, Gong Z, Zhu H and Qian
Y: In vivo tracking cystine/glutamate antiporter-mediated
cysteine/cystine pool under ferroptosis. Anal Chim Acta.
1125:66–75. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Koppula P, Zhuang L and Gan B: Cystine
transporter SLC7A11/xCT in cancer: Ferroptosis, nutrient
dependency, and cancer therapy. Protein Cell. 12:599–620. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Wang Y, Zheng L, Shang W, Yang Z, Li T,
Liu F, Shao W, Lv L, Chai L, Qu L, et al: Wnt/beta-catenin
signaling confers ferroptosis resistance by targeting GPX4 in
gastric cancer. Cell Death Differ. 29:2190–2202. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Xia C, Xing X, Zhang W, Wang Y, Jin X,
Wang Y, Tian M, Ba X and Hao F: Cysteine and homocysteine can be
exploited by GPX4 in ferroptosis inhibition independent of GSH
synthesis. Redox Biol. 69:1029992024. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Wang F and Min J: DHODH tangoing with GPX4
on the ferroptotic stage. Signal Transduct Target Ther. 6:2442021.
View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Hu Q, Wei W, Wu D, Huang F, Li M, Li W,
Yin J, Peng Y, Lu Y, Zhao Q and Liu L: Blockade of GCH1/BH4 axis
activates ferritinophagy to mitigate the resistance of colorectal
cancer to erastin-induced ferroptosis. Front Cell Dev Biol.
10:8103272022. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Kraft VAN, Bezjian CT, Pfeiffer S,
Ringelstetter L, Müller C, Zandkarimi F, Merl-Pham J, Bao X,
Anastasov N, Kössl J, et al: GTP cyclohydrolase
1/tetrahydrobiopterin counteract ferroptosis through lipid
remodeling. ACS Cent Sci. 6:41–53. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Feng Y, Feng Y, Gu L, Mo W, Wang X, Song
B, Hong M, Geng F, Huang P, Yang H, et al: Tetrahydrobiopterin
metabolism attenuates ROS generation and radiosensitivity through
LDHA S-nitrosylation: Novel insight into radiogenic lung injury.
Exp Mol Med. 56:1107–1122. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Soula M, Weber RA, Zilka O, Alwaseem H, La
K, Yen F, Molina H, Garcia-Bermudez J, Pratt DA and Birsoy K:
Metabolic determinants of cancer cell sensitivity to canonical
ferroptosis inducers. Nat Chem Biol. 16:1351–1360. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Lv Y, Wu M, Wang Z and Wang J:
Ferroptosis: From regulation of lipid peroxidation to the treatment
of diseases. Cell Biol Toxicol. 39:827–851. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Zhang S, Kang L, Dai X, Chen J, Chen Z,
Wang M, Jiang H, Wang X, Bu S, Liu X, et al: Manganese induces
tumor cell ferroptosis through type-I IFN dependent inhibition of
mitochondrial dihydroorotate dehydrogenase. Free Radic Biol Med.
193:202–212. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Amos A, Amos A, Wu L and Xia H: The
Warburg effect modulates DHODH role in ferroptosis: A review. Cell
Commun Signal. 21:1002023. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Mao C, Liu X, Zhang Y, Lei G, Yan Y, Lee
H, Koppula P, Wu S, Zhuang L, Fang B, et al: DHODH-mediated
ferroptosis defence is a targetable vulnerability in cancer.
Nature. 593:586–590. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Desler C, Durhuus JA, Hansen TLL, Anugula
S, Zelander NT, Bøggild S and Rasmussen LJ: Partial inhibition of
mitochondrial-linked pyrimidine synthesis increases tumorigenic
potential and lysosome accumulation. Mitochondrion. 64:73–81. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Tarangelo A, Rodencal J, Kim JT, Magtanong
L, Long JZ and Dixon SJ: Nucleotide biosynthesis links glutathione
metabolism to ferroptosis sensitivity. Life Sci Alliance.
5:e2021011572022. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Yang C, Zhao Y, Wang L, Guo Z, Ma L, Yang
R, Wu Y, Li X, Niu J, Chu Q, et al: De novo pyrimidine biosynthetic
complexes support cancer cell proliferation and ferroptosis
defence. Nat Cell Biol. 25:836–847. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Liu Y, Lu S, Wu LL, Yang L, Yang L and
Wang J: The diversified role of mitochondria in ferroptosis in
cancer. Cell Death Dis. 14:5192023. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Liang D, Feng Y, Zandkarimi F, Wang H,
Zhang Z, Kim J, Cai Y, Gu W, Stockwell BR and Jiang X: Ferroptosis
surveillance independent of GPX4 and differentially regulated by
sex hormones. Cell. 186:2748–64.e22. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Sun S, Shen J, Jiang J, Wang F and Min J:
Targeting ferroptosis opens new avenues for the development of
novel therapeutics. Signal Transduct Target Ther. 8:3722023.
View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Li P, Xu J, Xu B, Hu X, Xiong Y, Wang Y
and Liu P: NR5A2 (located on chromosome 1q32) inhibits ferroptosis
and promotes drug resistance by regulating phospholipid remodeling
in multiple myeloma. Int J Biol Sci. 21:5789–5801. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Phat NK, Tien NTN, Anh NK, Yen NTH, Lee
YA, Trinh HKT, Le KM, Ahn S, Cho YS, Park S, et al: Alterations of
lipid-related genes during anti-tuberculosis treatment: insights
into host immune responses and potential transcriptional
biomarkers. Front Immunol. 14:12103722023. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Nguyen HP, Yi D, Lin F, Viscarra JA,
Tabuchi C, Ngo K, Shin G, Lee AY, Wang Y and Sul HS: Aifm2, a NADH
oxidase, supports robust glycolysis and is required for cold- and
diet-induced thermogenesis. Mol Cell. 77:600–617.e4. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Lv Y, Liang C, Sun Q, Zhu J, Xu H, Li X,
Li YY, Wang Q, Yuan H, Chu B and Zhu D: Structural insights into
FSP1 catalysis and ferroptosis inhibition. Nat Commun. 14:59332023.
View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Guo J, Chen L and Ma M: Ginsenoside Rg1
suppresses ferroptosis of renal tubular epithelial cells in
sepsis-induced acute kidney injury via the FSP1-CoQ10-
NAD(P)H pathway. Curr Med Chem. 31:2119–2132. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Mikac S, Dziadosz A, Padariya M, Kalathiya
U, Fahraeus R, Marek-Trzonkowska N, Chruściel E, Urban-Wójciuk Z,
Papak I, Arcimowicz Ł, et al: Keap1-resistant ΔN-Nrf2 isoform does
not translocate to the nucleus upon electrophilic stress. bioRxiv.
2022.06. 10.495609. 2022.
|
|
78
|
Zhang Q, Sun T, Yu F, Liu W, Gao J, Chen
J, Zheng H, Liu J, Miao C, Guo H, et al: PAFAH2 suppresses
synchronized ferroptosis to ameliorate acute kidney injury. Nat
Chem Biol. 20:835–846. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Su ZY, Siak PY, Lwin YY and Cheah SC:
Epidemiology of nasopharyngeal carcinoma: Current insights and
future outlook. Cancer Metastasis Rev. 43:919–939. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Siak PY, Khoo AS, Leong CO, Hoh BP and
Cheah SC: Current status and future perspectives about molecular
biomarkers of nasopharyngeal carcinoma. Cancers (Basel).
13:34902021. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Zheng MQ, Wang TM, Liao Y, Xue WQ, He YQ,
Wu ZY, Yang DW, Li DH, Deng CM, Jia YJ, et al: Nasopharyngeal
Epstein-Barr virus DNA loads in high-risk nasopharyngeal carcinoma
families: Familial aggregation and host heritability. J Med Virol.
92:3717–3725. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Liao Y, Tong XT, Zhou T, Xue WQ, Wang TM,
He YQ, Zheng MQ, Jia YJ, Yang DW, Wu YX, et al: Unveiling familial
aggregation of nasopharyngeal carcinoma: Insights from oral
microbiome dysbiosis. Cell Rep Med. 6:1019792025. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Li W, Liang L, Liu S, Yi H and Zhou Y:
FSP1: A key regulator of ferroptosis. Trends Mol Med. 29:753–764.
2023. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Ward NP and DeNicola GM: Long-sought
mediator of vitamin K recycling discovered. Nature. 608:673–674.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Feng H, Zhou Y, Wang L, Wang Y, Zhou S and
Tian F: Consumption of processed food and risk of nasopharyngeal
carcinoma: A systematic review and meta-analysis. Transl Cancer
Res. 11:872–879. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Zhong L, Krummenacher C, Zhang W, Hong J,
Feng Q, Chen Y, Zhao Q, Zeng MS, Zeng YX, Xu M, Zhang X, et al:
Urgency and necessity of Epstein-Barr virus prophylactic vaccines.
NPJ Vaccines. 7:1592022. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Lin JH, Wen CP, Jiang CQ, Yuan JM, Chen
CJ, Ho SY, Gao W, Zhang W, Wang R, Chien YC, et al: Smoking and
nasopharyngeal cancer: Individual data meta-analysis of six
prospective studies on 334 935 men. Int J Epidemiol. 50:975–986.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Arfaeinia H, Ghaemi M, Jahantigh A,
Soleimani F and Hashemi H: Secondhand and thirdhand smoke: A review
on chemical contents, exposure routes, and protective strategies.
Environ Sci Pollut Res Int. 30:78017–78029. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Feng R, Chang ET, Liu Q, Cai Y, Zhang Z,
Chen G, Huang QH, Xie SH, Cao SM, Zhang Y, et al: Intake of alcohol
and tea and risk of nasopharyngeal carcinoma: A population-based
case-control study in Southern China. Cancer Epidemiol Biomarkers
Prev. 30:545–553. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
George M, Reddy AP, Reddy PH and
Kshirsagar S: Unraveling the NRF2 confusion: Distinguishing nuclear
respiratory factor 2 from nuclear erythroid factor 2. Ageing Res
Rev. 98:1023532024. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Yan R, Lin B, Jin W, Tang L, Hu S and Cai
R: NRF2, a superstar of ferroptosis. Antioxidants (Basel).
12:17392023. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Yuan L, Wang Y, Li N, Yang X, Sun X, Tian
He and Zhang Y: Mechanism of action and therapeutic implications of
Nrf2/HO-1 in inflammatory bowel disease. Antioxidants (Basel).
13:10122024. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Wang D, Tang L, Zhang Y, Ge G, Jiang X, Mo
Y, Wu P, Deng X, Li L, Zuo S, et al: Regulatory pathways and drugs
associated with ferroptosis in tumors. Cell Death Dis. 13:5442022.
View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Huang HC, Tantoh DM, Hsu SY, Nfor ON,
Frank CL, Lung CC, Ho CC, Chen CY and Liaw YP: Association between
coarse particulate matter (PM10-2.5) and nasopharyngeal
carcinoma among Taiwanese men. J Investig Med. 68:419–424. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Xue WQ, Wang TM, Huang JW, Zhang JB, He
YQ, Wu ZY, Liao Y, Yuan LL, Mu J and Jia WH: A comprehensive
analysis of genetic diversity of EBV reveals potential high-risk
subtypes associated with nasopharyngeal carcinoma in China. Virus
Evol. 7:veab0102021. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Damania B, Kenney SC and Raab-Traub N:
Epstein-Barr virus: Biology and clinical disease. Cell.
185:3652–3670. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Manners O, Murphy JC, Coleman A, Hughes DJ
and Whitehouse A: Contribution of the KSHV and EBV lytic cycles to
tumourigenesis. Curr Opin Virol. 32:60–70. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Phan TG: Epstein-Barr virus and multiple
sclerosis: The dawn of a new age. Clin Transl Immunology.
12:e14572023. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Tyler KL: The enigmatic links between
Epstein-Barr virus infection and multiple sclerosis. J Clin Invest.
132:e1604682022. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Lyu L, Li Q and Wang C: EBV latency
programs: Molecular and epigenetic regulation and its role in
disease pathogenesis. J Med Virol. 97:e705012025. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Murray-Nerger LA, Lozano C, Burton EM,
Liao Y, Ungerleider NA, Guo R and Gewurz BE: The nucleic acid
binding protein SFPQ represses EBV lytic reactivation by promoting
histone H1 expression. Nat Commun. 15:41562024. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Yuan L, Li S, Chen Q, Xia T, Luo D, Li L,
Liu S, Guo S, Liu L, Du C, et al: EBV infection-induced GPX4
promotes chemoresistance and tumor progression in nasopharyngeal
carcinoma. Cell Death Differ. 29:1513–1527. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
He S, Luo C, Shi F, Zhou J and Shang L:
The emerging role of ferroptosis in EBV-associated cancer:
Implications for cancer therapy. Biology (Basel).
13:5432024.PubMed/NCBI
|
|
104
|
Ge A, Xiang W, Li Y, Zhao D, Chen J, Daga
P, Dai CC, Yang K, Yan Y, Hao M, et al: Broadening horizons: The
multifaceted role of ferroptosis in breast cancer. Front Immunol.
15:14557412024. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Li X, Zhang R, Zhao X and Zhuang X:
Advances in the role of FOXM1 and ferroptosis in the diagnosis,
treatment, and prognosis of hepatocellular carcinoma. Curr Protein
Pept Sci. Oct 28–2025.(Epub ahead of print). View Article : Google Scholar
|
|
106
|
Wu J, Zhu S, Wang P, Wang J, Huang J, Wang
T, Guo L, Liang D, Meng Q and Pan H: Regulators of epigenetic
change in ferroptosis-associated cancer (Review). Oncol Rep.
48:2152022. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Li J, Zhang XS, Xie D, Deng HX, Gao YF,
Chen QY, Huang WL, Masucci MG and Zeng YX: Expression of
immune-related molecules in primary EBV-positive Chinese
nasopharyngeal carcinoma: Associated with latent membrane protein 1
(LMP1) expression. Cancer Biol Ther. 6:1997–2004. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Abstracts from the 22nd International
Symposium on Signal Transduction at the Blood-Brain Barriers.
Würzburg, Germany. September 11–13, 2019. Fluids Barriers CNS. 16
(Suppl 2):292019.PubMed/NCBI
|
|
109
|
Verhoeven RJA, Tong S, Mok BWY, Liu J, He
S, Zong J, Chen Y, Tsao SW, Lung ML and Chen H: Epstein-Barr virus
BART long non-coding RNAs function as epigenetic modulators in
nasopharyngeal carcinoma. Front Oncol. 9:11202019. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Xu H, Koganti S, Li C, McIntosh MT and
Bhaduri-McIntosh S: STAT3, MYC, and EBNA1 cooperate through a
ZC3H18 transcriptional network to regulate survival and
proliferation of EBV-positive lymphomas. PLoS Pathog.
21:e10131662025. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Ji HZ, Chen L, Ren M, Li S, Liu TY, Chen
HJ, Yu HH and Sun Y: CXCL8 promotes endothelial-to-mesenchymal
transition of endothelial cells and protects cells from
erastin-induced ferroptosis via CXCR2-mediated activation of the
NF-κB signaling pathway. Pharmaceuticals (Basel). 16:12102023.
View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Verhoeven RJA, Tong S, Zong J, Chen Y,
Tsao SW, Pan J and Chen H: NF-κB signaling regulates epstein-barr
virus BamHI-Q-driven EBNA1 expression. Cancers (Basel). 10:1192018.
View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Yuan L, Zhang L, Yao N, Wu L, Liu J, Liu
F, Zhang H, Hu X, Xiong Y and Xia C: Upregulation of UGT1A1
expression by ursolic acid and oleanolic acid via the inhibition of
the PKC/NF-κB signaling pathway. Phytomedicine. 92:1537262021.
View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Iglesias-Matesanz P, Lacalle-Gonzalez C,
Lopez-Blazquez C, Ochieng' Otieno M, Garcia-Foncillas J and
Martinez-Useros J: Glutathione peroxidases: An emerging and
promising therapeutic target for pancreatic cancer treatment.
Antioxidants (Basel). 13:14052024. View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Morgos DT, Stefani C, Miricescu D, Greabu
M, Stanciu S, Nica S, Stanescu-Spinu II, Balan DG,
Balcangiu-Stroescu AE, Coculescu EC, et al: Targeting PI3K/AKT/mTOR
and MAPK signaling pathways in gastric cancer. Int J Mol Sci.
25:18482024. View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Tóthová Z, Šemeláková M, Solárová Z, Tomc
J, Debeljak N and Solár P: The role of PI3K/AKT and MAPK signaling
pathways in erythropoietin signalization. Int J Mol Sci.
22:76822021. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Chen K, Wang J, Guo L, Wang J, Yang L, Hu
T, Zhao Y, Wang X and Zhu Y: Lactobacillus johnsonii L531
ameliorates salmonella enterica serovar typhimurium diarrhea by
modulating iron homeostasis and oxidative stress via the IRP2
pathway. Nutrients. 15:11272023. View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Jia F, Li H, Jiao Q, Li C, Fu L, Cui C,
Jiang H and Zhang L: Deubiquitylase OTUD3 prevents Parkinson's
disease through stabilizing iron regulatory protein 2. Cell Death
Dis. 13:4182022. View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Jiao Q, Du X, Wei J, Li Y and Jiang H:
Oxidative stress regulated iron regulatory protein IRP2 through
FBXL5-mediated ubiquitination-proteasome way in SH-SY5Y cells.
Front Neurosci. 13:202019. View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Terzi EM, Sviderskiy VO, Alvarez SW,
Whiten GC and Possemato R: Iron-sulfur cluster deficiency can be
sensed by IRP2 and regulates iron homeostasis and sensitivity to
ferroptosis independent of IRP1 and FBXL5. Sci Adv. 7:eabg43022021.
View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Dasgupta S and Gan B: Ferroptosis
vulnerability in MYCN-driven neuroblastomas. Clin Transl Med.
12:e9632022. View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Hill RA and Liu YY:
N6-methyladenosine-RNA methylation promotes expression
of solute carrier family 7 member 11, an uptake transporter of
cystine for lipid reactive oxygen species scavenger glutathione
synthesis, leading to hepatoblastoma ferroptosis resistance. Clin
Transl Med. 12:e8892022. View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Li X, Qi H, Zhang X, Liang H and Zeng N:
Jing-Fang n-butanol extract and its isolated JFNE-C inhibit
ferroptosis and inflammation in LPS induced RAW264.7 macrophages
via STAT3/p53/SLC7A11 signaling pathway. J Ethnopharmacol.
316:1166892023. View Article : Google Scholar : PubMed/NCBI
|
|
124
|
Li X, Zou Y, Fu YY, Xing J, Wang KY, Wan
PZ and Zhai XY: A-Lipoic acid alleviates folic acid-induced renal
damage through inhibition of ferroptosis. Front Physiol.
12:6805442021. View Article : Google Scholar : PubMed/NCBI
|
|
125
|
Zhao X, Shi D, Sun L, Gong Z, Liu W, Zhang
Y and Luo B: Epstein-Barr virus modulates iron metabolism and
ferritin expression to promote tumorigenesis in gastric cancer. J
Mol Histol. 56:2312025. View Article : Google Scholar : PubMed/NCBI
|
|
126
|
Altamura S, Colucci S, Schmidt J, Muedder
K, Neves J, Hentze M and Muckenthaler M: Hepatocyte iron content
controls BMP6-dependent hepcidin regulation. Blood. 132 (Suppl
1):S3626. 2018. View Article : Google Scholar
|
|
127
|
Cabrera C, Frisk C, Löfström U, Lyngå P,
Linde C, Hage C, Persson H, Eriksson MJ, Wallén H, Persson B and
Ekström M: Relationship between iron deficiency and expression of
genes involved in iron metabolism in human myocardium and skeletal
muscle. Int J Cardiol. 379:82–88. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Huang H, Mei L, Wang L, Bai Y, Gao K, Song
J, Jiang M, Chen Y, Zhang S, Pang B, et al: Ferroptosis contributes
to lead-induced cochlear spiral ganglion neurons injury.
Toxicology. 509:1539382024. View Article : Google Scholar : PubMed/NCBI
|
|
129
|
Ameziane El Hassani R, Buffet C,
Leboulleux S and Dupuy C: Oxidative stress in thyroid carcinomas:
Biological and clinical significance. Endocr Relat Cancer.
26:R131–R143. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
130
|
Backert S, Linz B and Tegtmeyer N:
Helicobacter pylori-induced host cell DNA damage and genetics of
gastric cancer development. Curr Top Microbiol Immunol.
444:185–206. 2023.PubMed/NCBI
|
|
131
|
da Silva MS, Segatto M, Pavani RS,
Gutierrez-Rodrigues F, Bispo VD, de Medeiros MH, Calado RT, Elias
MC and Cano MI: Consequences of acute oxidative stress in
Leishmania amazonensis: From telomere shortening to the selection
of the fittest parasites. Biochim Biophys Acta Mol Cell Res.
1864:138–150. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
132
|
Lee J, Lim JW and Kim H: Astaxanthin
inhibits oxidative stress-induced Ku protein degradation and
apoptosis in gastric epithelial cells. Nutrients. 14:39392022.
View Article : Google Scholar : PubMed/NCBI
|
|
133
|
Sekhar KR, Hanna DN, Cyr S, Baechle JJ,
Kuravi S, Balusu R, Rathmell K and Baregamian N: Glutathione
peroxidase 4 inhibition induces ferroptosis and mTOR pathway
suppression in thyroid cancer. Sci Rep. 12:193962022. View Article : Google Scholar : PubMed/NCBI
|
|
134
|
Dong Q, Shen X, Fang G, Shi J, Zhu X, Du
J, Zhang H and Ge C: Theory-screened Prussian blue analogues-based
nanozymes for promoting diabetic wound healing via ferroptosis
inhibition. Mater Today Bio. 32:1018392025. View Article : Google Scholar : PubMed/NCBI
|
|
135
|
Yang R, Zhou Y, Zhang T, Wang S, Wang J,
Cheng Y, Li H, Jiang W, Yang Z and Zhang X: The transcription
factor HBP1 promotes ferroptosis in tumor cells by regulating the
UHRF1-CDO1 axis. PLoS Biol. 21:e30018622023. View Article : Google Scholar : PubMed/NCBI
|
|
136
|
Zhu JF, Liu Y, Li WT, Li MH, Zhen CH, Sun
PW, Chen JX, Wu WH and Zeng W: Ibrutinib facilitates the
sensitivity of colorectal cancer cells to ferroptosis through
BTK/NRF2 pathway. Cell Death Dis. 14:1512023. View Article : Google Scholar : PubMed/NCBI
|
|
137
|
Hitt MM, Allday MJ, Hara T, Karran L,
Jones MD, Busson P, Tursz T, Ernberg I and Griffin BE: EBV gene
expression in an NPC-related tumour. EMBO J. 8:2639–2651. 1989.
View Article : Google Scholar : PubMed/NCBI
|
|
138
|
Chiu SH, Wu MC, Wu CC, Chen YC, Lin SF,
Hsu JTA, ang CS, Tsai CH, Takada K, Chen MR and Chen JY:
Epstein-Barr virus BALF3 has nuclease activity and mediates mature
virion production during the lytic cycle. J Virol. 88:4962–4975.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
139
|
Ragoczy T, Heston L and Miller G: The
Epstein-Barr virus Rta protein activates lytic cycle genes and can
disrupt latency in B lymphocytes. J Virol. 72:7978–7984. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
140
|
Germini D, Sall FB, Shmakova A, Wiels J,
Dokudovskaya S, Drouet E and Vassetzky Y: Oncogenic properties of
the EBV ZEBRA protein. Cancers (Basel). 12:14792020. View Article : Google Scholar : PubMed/NCBI
|
|
141
|
Meng C, Dai X, Sun L, Huang D, Xu X and
Cheng Y: Meeting abstracts from the 10th international conference
on cGMP: Generators, effectors and therapeutic implications. J
Transl Med. Jan 31–2023.(Epub ahead of print).
|
|
142
|
Meng C, Dai X, Sun L, Huang D, Xu X, Cheng
Y and Zhang W: ZDHHC21-driven S-palmitoylation of Themis regulates
the function of T cells and maintains homeostatic balance. Cell
Commun Signal. 23:4012025. View Article : Google Scholar : PubMed/NCBI
|
|
143
|
Png YT, Yang AZY, Lee MY, Chua MJM and Lim
CM: The role of NK cells in EBV infection and EBV-associated NPC.
Viruses. 13:3002021. View Article : Google Scholar : PubMed/NCBI
|
|
144
|
Hsu WL, Tao J, Fu S, Yu KJ, Simon J, Chen
TC, Chen CJ, Goldstein AM, Yu K, Hildesheim A, et al: Kinetics of
EBV antibody-based NPC risk scores in Taiwan NPC multiplex
families. Int J Cancer. 155:1400–1408. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
145
|
Wang J and Cao X: Dietary long-chain fatty
acid metabolism boosts antitumor immune response. Cancer Commun
(Lond). 44:580–583. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
146
|
Peng WX and Mo YY: Connecting
N6-methyladenosine modification to ferroptosis resistance in
hepatoblastoma. Clin Transl Med. 12:e8202022. View Article : Google Scholar : PubMed/NCBI
|
|
147
|
Chiu SH, Wu CC, Fang CY, Yu SL, Hsu HY,
Chow YH and Chen JY: Epstein-Barr virus BALF3 mediates genomic
instability and progressive malignancy in nasopharyngeal carcinoma.
Oncotarget. 5:8583–8601. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
148
|
Benedetti F, Curreli S, Gallo RC and Zella
D: Tampering of viruses and bacteria with host DNA repair:
Implications for cellular transformation. Cancers (Basel).
13:2412021. View Article : Google Scholar : PubMed/NCBI
|
|
149
|
Dylawerska A, Barczak W, Wegner A,
Golusinski W and Suchorska WM: Association of DNA repair genes
polymorphisms and mutations with increased risk of head and neck
cancer: A review. Med Oncol. 34:1972017. View Article : Google Scholar : PubMed/NCBI
|
|
150
|
Mekonnen N, Yang H and Shin YK: Homologous
recombination deficiency in ovarian, breast, colorectal,
pancreatic, non-small cell lung and prostate cancers, and the
mechanisms of resistance to PARP inhibitors. Front Oncol.
12:8806432022. View Article : Google Scholar : PubMed/NCBI
|
|
151
|
No authors listed. The international
headache congress-IHS and EHF joint congress 2021: Late breaking
abstracts: Virtual. 8–12 September 2021. J Headache Pain. 22 (Suppl
2):S1302021. View Article : Google Scholar
|
|
152
|
Abstracts from the 17th European headache
congress (EHC). J Headache Pain. 25 (Suppl 1):1232024. View Article : Google Scholar
|
|
153
|
Li F, Xu T, Chen P, Sun R, Li C, Zhao X,
Ou J, Li J, Liu T, Zeng M, et al: Platelet-derived extracellular
vesicles inhibit ferroptosis and promote distant metastasis of
nasopharyngeal carcinoma by upregulating ITGB3. Int J Biol Sci.
18:5858–5872. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
154
|
Jin N, Qian YY, Jiao XF, Wang Z, Li X, Pan
W, Jiang JK, Huang P, Wang SY, Jin P, et al: Niraparib restricts
intraperitoneal metastases of ovarian cancer by eliciting
CD36-dependent ferroptosis. Redox Biol. 80:1035282025. View Article : Google Scholar : PubMed/NCBI
|
|
155
|
Zhang B, Hou Q, Zhang X, Ma Y, Yuan J, Li
S, Zhao X, Sun L, Wang H and Zheng H: Anesthetic propofol inhibits
ferroptosis and aggravates distant cancer metastasis via Nrf2
upregulation. Free Radic Biol Med. 195:298–308. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
156
|
Zhang R, Shen Y, Zhou X, Li J, Zhao H,
Zhang Z, Zhao J, Jin H, Guo S, Ding H, et al: Hypoxia-tropic
delivery of nanozymes targeting transferrin receptor 1 for
nasopharyngeal carcinoma radiotherapy sensitization. Nat Commun.
16:8902025. View Article : Google Scholar : PubMed/NCBI
|
|
157
|
Wang HH, Fan SQ, Zhan YT, Peng SP and Wang
WY: Suppression of the SLC7A11/glutathione axis causes ferroptosis
and apoptosis and alters the mitogen-activated protein kinase
pathway in nasopharyngeal carcinoma. Int J Biol Macromol.
254:1279762024. View Article : Google Scholar : PubMed/NCBI
|
|
158
|
Nhung DT, Yousif OEA and Kwon B: Sorafenib
induces ferroptosis in human renal cell carcinoma cells through
CCAT/enhancer-binding protein homologous protein. Biochem Biophys
Rep. 43:1021432025.PubMed/NCBI
|
|
159
|
Liu F, Tang L, Liu H, Chen Y, Xiao T, Gu
W, Yang H, Wang H and Chen P: Cancer-associated fibroblasts secrete
FGF5 to inhibit ferroptosis to decrease cisplatin sensitivity in
nasopharyngeal carcinoma through binding to FGFR2. Cell Death Dis.
15:2792024. View Article : Google Scholar : PubMed/NCBI
|
|
160
|
Chen Y, Feng Y, Lin Y, Zhou X, Wang L,
Zhou Y, Lin K and Cai L: GSTM3 enhances radiosensitivity of
nasopharyngeal carcinoma by promoting radiation-induced ferroptosis
through USP14/FASN axis and GPX4. Br J Cancer. 130:755–768. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
161
|
Pu X, Wu H, Liu X and Yang F: PRMT4
reduced erastin-induced ferroptosis in nasopharyngeal carcinoma
cisplatin-resistant cells by Nrf2/GPX4 pathway. J Environ Pathol
Toxicol Oncol. 44:57–71. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
162
|
Du P, Luo K, Li G, Zhu J, Xiao Q, Li Y and
Zhang X: PRMT4 promotes hepatocellular carcinoma progression by
activating AKT/mTOR signaling and indicates poor prognosis. Int J
Med Sci. 18:3588–3598. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
163
|
Berman AY, Manna S, Schwartz NS, Katz YE,
Sun Y, Behrmann CA, Yu JJ, Plas DR, Alayev A and Holz MK: ERRα
regulates the growth of triple-negative breast cancer cells via
S6K1-dependent mechanism. Signal Transduct Target Ther.
2:e170352017. View Article : Google Scholar : PubMed/NCBI
|
|
164
|
Xiao H, Zhang F, Zou Y, Li J, Liu Y and
Huang W: The function and mechanism of long non-coding RNA-ATB in
cancers. Front Physiol. 9:3212018. View Article : Google Scholar : PubMed/NCBI
|
|
165
|
Cui X, Gong Y, Ge J, Feng X, Xiong X, Shi
Z, Zheng Q, Li D and Bi S: α-Solanine induces ferroptosis in
nasopharyngeal carcinoma via targeting HSP90α/p53 axis. J Funct
Foods. 104:1055172023. View Article : Google Scholar
|
|
166
|
Yap TA, Bessudo A, Hamilton E, Sachdev J,
Patel MR, Rodon J, Evilevitch L, Duncan M, Guo W, Kumar S, et al:
IOLite: Phase 1b trial of doublet/triplet combinations of
dostarlimab with niraparib, carboplatin-paclitaxel, with or without
bevacizumab in patients with advanced cancer. J Immunother Cancer.
10:e0039242022. View Article : Google Scholar : PubMed/NCBI
|
|
167
|
Wang Y, Xu H, Sa Q, Zhou Y, Cheng H, Gao
R, Xu B and Wang J: Efficacy and safety of vascular-targeting
agents in advanced soft tissue sarcoma: A systematic review and
network meta-analysis. Ther Adv Med Oncol.
17:175883592513789342025. View Article : Google Scholar : PubMed/NCBI
|
|
168
|
Ochsenreither S, Fiedler WM, Conte GD,
Macchini M, Matos I, Habel B, Ahrens-Fath I, Raspagliesi F, Lorusso
D, Keilholz U, et al: Safety and preliminary activity results of
the GATTO study, a phase Ib study combining the anti-TA-MUC1
antibody gatipotuzumab with the anti-EGFR tomuzotuximab in patients
with refractory solid tumors. ESMO Open. 7:1004472022. View Article : Google Scholar : PubMed/NCBI
|
|
169
|
Zargarani N, Kavousi M and Aliasgari E: A
potential new strategy for BC treatment: NPs containing solanine
and evaluation of its anticancer and antimetastatic properties. BMC
Cancer. 25:8602025. View Article : Google Scholar : PubMed/NCBI
|
|
170
|
Chowański S, Winkiel M, Szymczak-Cendlak
M, Marciniak P, Mańczak D, Walkowiak-Nowicka K, Spochacz M, Bufo
SA, Scrano L and Adamski Z: Solanaceae glycoalkaloids: α-solanine
and α-chaconine modify the cardioinhibitory activity of verapamil.
Pharm Biol. 60:1317–1330. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
171
|
Li W, Liu Y, Wei M, Yang Z, Tang H and
Huang W: Chondrocyte-targeted α-Solanine through HIF-1α regulating
glycolysis to reduce the ferroptosis of chondrocyte in
osteoarthritis. Int Immunopharmacol. 159:1148412025. View Article : Google Scholar : PubMed/NCBI
|
|
172
|
Wei Z, Wang H, Zhong R, Chen L, Vigors S
and Zhang H: Biodegradation of α-solanine and α-chaconine: Insights
into microbial detoxification and enzymatic deglycosylation
pathways. Food Chem X. 31:1029682025. View Article : Google Scholar : PubMed/NCBI
|
|
173
|
Zhou J, Wu J, Fu F, Yao S, Zheng W, Du W,
Luo H, Jin H, Tong P, Wu C and Ruan H: α-Solanine attenuates
chondrocyte pyroptosis to improve osteoarthritis via suppressing
NF-κB pathway. J Cell Mol Med. 28:e181322024. View Article : Google Scholar : PubMed/NCBI
|
|
174
|
Seven D, Dalan AB and Bayrak ÖF: Targeting
GSTM3 for therapeutic potential in advanced prostate cancer. BMC
Cancer. 25:14932025. View Article : Google Scholar : PubMed/NCBI
|
|
175
|
Llavanera M, Ribas-Maynou J,
Delgado-Bermúdez A, Recuero S, Salas-Huetos A, Benet J and Yeste M:
P-049 sperm GSTM3: A potential molecular biomarker for sperm
quality and male (in)fertility. Hum Reprod. 37 (Suppl
1):deac104.111. 2022. View Article : Google Scholar
|
|
176
|
Wang B, Gu Q and Li J: DOC-2/DAB2
interactive protein regulates proliferation and mobility of
nasopharyngeal carcinoma cells by targeting PI3K/Akt pathway. Oncol
Rep. 38:317–324. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
177
|
Niu Z, Liu H, Zhou M, Wang H, Liu Y, Li X,
Xiong W, Ma J, Li X and Li G: Knockdown of c-Myc inhibits cell
proliferation by negatively regulating the Cdk/Rb/E2F pathway in
nasopharyngeal carcinoma cells. Acta Biochim Biophys Sin
(Shanghai). 47:183–191. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
178
|
Soulage CO, Pelletier CC, Florens N,
Lemoine S, Dubourg L, Juillard L and Guebre-Egziabher F: Two toxic
lipid aldehydes, 4-hydroxy-2-hexenal (4-HHE) and
4-hydroxy-2-nonenal (4-HNE), accumulate in patients with chronic
kidney disease. Toxins (Basel). 12:5672020. View Article : Google Scholar : PubMed/NCBI
|
|
179
|
Li Y, Zhao T, Li J, Xia M, Li Y, Wang X,
Liu C, Zheng T, Chen R, Kan D, et al: Oxidative stress and
4-hydroxy-2-nonenal (4-HNE): Implications in the pathogenesis and
treatment of aging-related diseases. J Immunol Res.
2022:22339062022.PubMed/NCBI
|
|
180
|
Globisch M, Kaden D and Henle T:
4-Hydroxy-2-nonenal (4-HNE) and Its lipation product
2-pentylpyrrole lysine (2-PPL) in peanuts. J Agric Food Chem.
63:5273–81. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
181
|
Llavanera M, Delgado-Bermúdez A,
Fernandez-Fuertes B, Recuero S, Mateo Y, Bonet S, Barranco I and
Yeste M: GSTM3, but not IZUMO1, is a cryotolerance marker of boar
sperm. J Anim Sci Biotechnol. 10:612019. View Article : Google Scholar : PubMed/NCBI
|
|
182
|
Li B, Zhou J, Zhang G, Wang Y, Kang L, Wu
J, Chen J and Guan H: Relationship between the altered expression
and epigenetics of GSTM3 and age-related cataract. Invest
Ophthalmol Vis Sci. 57:4721–4732. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
183
|
Mandic-Maravic V, Mitkovic-Voncina M,
Pljesa-Ercegovac M, Savic-Radojevic A, Djordjevic M, Ercegovac M,
Pekmezovic T, Simic T and Pejovic-Milovancevic M: Glutathione
S-transferase polymorphisms and clinical characteristics in autism
spectrum disorders. Front Psychiatry. 12:6723892021. View Article : Google Scholar : PubMed/NCBI
|
|
184
|
Li X, Gou J, Li H and Yang X:
Bioinformatic analysis of the expression and prognostic value of
chromobox family proteins in human breast cancer. Sci Rep.
10:177392020. View Article : Google Scholar : PubMed/NCBI
|
|
185
|
Li G, Cai Y, Wang C, Huang M and Chen J:
LncRNA GAS5 regulates the proliferation, migration, invasion and
apoptosis of brain glioma cells through targeting GSTM3 expression.
The effect of LncRNA GAS5 on glioma cells. J Neurooncol.
143:525–536. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
186
|
Chen T, Jinlin D, Wang F, Yuan Z, Xue J,
Lu T, Huang W, Liu Y and Zhang Y: GSTM3 deficiency impedes DNA
mismatch repair to promote gastric tumorigenesis via
CAND1/NRF2-KEAP1 signaling. Cancer Lett. 538:2156922022. View Article : Google Scholar : PubMed/NCBI
|
|
187
|
Wu Y, Jia Q, Tang Q, Deng H, He Y and Tang
F: Berberine-mediated ferroptosis through system
Xc−/GSH/GPX4 axis inhibits metastasis of nasopharyngeal
carcinoma. J Cancer. 15:685–698. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
188
|
Hou J, Zi L, Shi M, Wang Y, Gao F and Chen
W: The contribution of SLC7A11-mediated ferroptosis to cardiac
injury in iron overload cardiomyopathy: An in vitro study. Eur
Heart J. 45 (Suppl 1):ehae666.3648. 2024. View Article : Google Scholar
|
|
189
|
Wang F, Sun Z, Zhang Q, Yang H, Yang G,
Yang Q, Zhu Y, Wu W, Xu W and Wu X: Curdione induces ferroptosis
mediated by m6A methylation via METTL14 and YTHDF2 in colorectal
cancer. Chin Med. 18:1222023. View Article : Google Scholar : PubMed/NCBI
|
|
190
|
Zhao YY, Yang YQ, Sheng HH, Tang Q, Han L,
Wang SM and Wu WY: GPX4 plays a crucial role in Fuzheng Kang'ai
decoction-induced non-small cell lung cancer cell ferroptosis.
Front Pharmacol. 13:8516802022. View Article : Google Scholar : PubMed/NCBI
|
|
191
|
Gao X, Guo N, Xu H, Pan T, lei H, Yan A,
Mi Y and Xu L: Ibuprofen induces ferroptosis of glioblastoma cells
via downregulation of nuclear factor erythroid 2-related factor 2
signaling pathway. Anticancer Drugs. 31:27–34. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
192
|
Zheng J, Fang Y, Zhang M, Gao Q, Li J,
Yuan H, Jin W, Lin Z and Lin W: Mechanisms of ferroptosis in
hypoxic-ischemic brain damage in neonatal rats. Exp Neurol.
372:1146412024. View Article : Google Scholar : PubMed/NCBI
|
|
193
|
Yujiao C, Meng Z, Shanshan L, Wei W,
Yipeng W and Chenghong Y: Exposure to bisphenol A induces abnormal
fetal heart development by promoting ferroptosis. Ecotoxicol
Environ Saf. 255:1147532023. View Article : Google Scholar : PubMed/NCBI
|
|
194
|
Wang S, Xu Z, Cai B and Chen Q: Berberine
as a potential multi-target agent for metabolic diseases: A review
of investigations for berberine. Endocr Metab Immune Disord Drug
Targets. 21:971–979. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
195
|
Chen J, Peng W, Yang W, You Z and Zou Y:
Berberine inhibits high glucose-induced ferroptosis in retinal
vascular endothelial cells: Mechanism and implications. Exp Eye
Res. 259:1105312025. View Article : Google Scholar : PubMed/NCBI
|
|
196
|
Bao L, Jin Y, Han J, Wang W, Qian L and Wu
W: Berberine regulates GPX4 to inhibit ferroptosis of islet β
cells. Planta Med. 89:254–261. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
197
|
Shah D, Challagundla N, Dave V, Patidar A,
Saha B, Nivsarkar M, Trivedi VB and Agrawal-Rajput R: Berberine
mediates tumor cell death by skewing tumor-associated
immunosuppressive macrophages to inflammatory macrophages.
Phytomedicine. 99:1539042022. View Article : Google Scholar : PubMed/NCBI
|
|
198
|
Sun Q, Tu K, Xu Q, Yan L, Yang S, Wang J,
Lv L, Liu H and Cai L: Berberine suppresses colorectal cancer
progression by inducing ferroptosis-mediated energy metabolism
disorders. J Adv Res. Oct 24–2025.(Epub ahead of print). View Article : Google Scholar
|
|
199
|
Xie Z, Zhou Y, Lin M and Huang C: Binding
of berberine to PEBP1 synergizes with sorafenib to induce the
ferroptosis of hepatic stellate cells. Amino Acids. 55:1867–1878.
2023. View Article : Google Scholar : PubMed/NCBI
|
|
200
|
Zhang Y, Liu X, Yu M, Xu M, Xiao Y, Ma W,
Huang L, Li X and Ye X: Berberine inhibits proliferation and
induces G0/G1 phase arrest in colorectal cancer cells by
downregulating IGF2BP3. Life Sci. 260:1184132020. View Article : Google Scholar : PubMed/NCBI
|
|
201
|
Eke I, Makinde AY, Aryankalayil MJ,
Sandfort V, Palayoor ST, Rath BH, Liotta L, Pierobon M, Petricoin
EF, Brown MF, et al: Exploiting radiation-induced signaling to
increase the susceptibility of resistant cancer cells to targeted
drugs: AKT and mTOR inhibitors as an example. Mol Cancer Ther.
17:355–367. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
202
|
Bagnulo M and García-Martínez A: When less
is more: BBR versus LEDBAT++. Comput Netw. 219:1094602022.
View Article : Google Scholar
|
|
203
|
Atxutegi E, Liberal F, Haile HK, Grinnemo
KJ, Brunstrom A and Arvidsson Å: On the use of TCP BBR in cellular
networks. IEEE Commun Mag. 56:172–179. 2018. View Article : Google Scholar
|
|
204
|
Abdelmawgood IA, Kotb MA, Hassan HS,
Mahana NA, Rochdi AM, Sayed NH, Elsafoury RH, Saber AM, Youssef MN,
Waheeb NG, et al: Gentisic acid attenuates ovalbumin-induced airway
inflammation, oxidative stress, and ferroptosis through the
modulation of Nrf2/HO-1 and NF-κB signaling pathways. Int
Immunopharmacol. 146:1137642025. View Article : Google Scholar : PubMed/NCBI
|
|
205
|
Zhong X, Zhang Z, Shen H, Xiong Y, Shah
YM, Liu Y, Liu Y, Fan XG and Rui L: Hepatic NF-κB-inducing kinase
and inhibitor of NF-κB kinase subunit α promote liver oxidative
stress, ferroptosis, and liver injury. Hepatol Commun. 5:1704–1720.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
206
|
Zhou JC, Wu B, Zhang JJ and Zhang W:
Lupeol triggers oxidative stress, ferroptosis, apoptosis and
restrains inflammation in nasopharyngeal carcinoma via AMPK/NF-κB
pathway. Immunopharmacol Immunotoxicol. 44:621–631. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
207
|
Wang Z, Di Y, Ye L, Fang W, Wen X, Zhang
X, Qin J, Wang Y, Hu K, Zhu Z, et al: NANS suppresses NF-κB
signaling to promote ferroptosis by perturbing iron homeostasis.
Cell Rep. 44:1157012025. View Article : Google Scholar : PubMed/NCBI
|
|
208
|
Wu S, Zhou Y, Liang J, Ying P, Situ Q, Tan
X and Zhu J: Upregulation of NF-κB by USP24 aggravates ferroptosis
in diabetic cardiomyopathy. Free Radic Biol Med. 210:352–366. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
209
|
Luo X, Gong Y, Jiang Q, Wang Q, Li S and
Liu L: Isoquercitrin promotes ferroptosis and oxidative stress in
nasopharyngeal carcinoma via the AMPK/NF-κB pathway. J Biochem Mol
Toxicol. 38:e235422024. View Article : Google Scholar : PubMed/NCBI
|
|
210
|
Song X, Zhu H, Chen Z, Wang Y, Zhang J,
Wang Y, Rong P and Wang J: Transcutaneous auricular vagus nerve
stimulation alleviates inflammation-induced depression by
modulating peripheral-central inflammatory cytokines and the NF-κB
pathway in rats. Front Immunol. 16:15360562025. View Article : Google Scholar : PubMed/NCBI
|
|
211
|
Gong X, Yang Y, Huang L, Zhang Q, Wan RZ,
Zhang P and Zhang X: Antioxidation, anti-inflammation and
anti-apoptosis by paeonol in LPS/d-GalN-induced acute liver failure
in mice. Int Immunopharmacol. 46:124–132. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
212
|
Zeng MY and Tong QY: Anti-inflammation
effects of sinomenine on macrophages through suppressing activated
TLR4/NF-κB signaling pathway. Curr Med Sci. 40:130–137. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
213
|
Zhao S, Zuo W, Chen H, Bao T, Liu X, Sun T
and Wang S: Effects of pilose antler peptide on bleomycin-induced
pulmonary fibrosis in mice. Biomed Pharmacother. 109:2078–2083.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
214
|
Zhang J, Qi S, Du Y, Dai H and Lu N:
Effect of quercetin on inhibiting gefitinib-activated non-small
cell lung cancer-induced cell pyroptosis in cardiomyocytes via
modulating mitochondrial autophagy mediated by the
SHP2/ROS/AMPK/XBP-1/DJ-1 signaling pathway. Oncol Rep. 53:572025.
View Article : Google Scholar : PubMed/NCBI
|
|
215
|
Wang N, Chen HQ, Zeng Y, Shi Y, Zhang Z,
Li JY, Zhou SM, Li YW, Deng SW, Han X, et al: Benzo(a)pyrene
promotes the malignant progression of malignant-transformed BEAS-2B
cells by regulating YTH N6-methyladenosine RNA binding protein 1 to
inhibit ferroptosis. Toxicology. 507:1538862024. View Article : Google Scholar : PubMed/NCBI
|
|
216
|
Shao C, Luo T, Wang S, Li Z, Yu X, Wu Y,
Jiang S, Zhou B, Song Q, Song S, et al: Selenium nanoparticles
alleviates cadmium induced hepatotoxicity by inhibiting ferroptosis
and oxidative stress in vivo and in vitro. Chemosphere.
364:1430042024. View Article : Google Scholar : PubMed/NCBI
|
|
217
|
Meng J, Hu C, Qian Z, Yue J, Zhang S,
Jiang W, Su R, Jiang G and Huang G: Isoquercitrin inhibits
ferroptosis and ameliorates insulin resistance: Evidence from
network pharmacology and in vitro studies. Biochem Biophys Res
Commun. 781:1525002025. View Article : Google Scholar : PubMed/NCBI
|
|
218
|
Lee J, Jang CH, Kim Y, Oh J and Kim JS:
Quercetin-Induced glutathione depletion sensitizes colorectal
cancer cells to oxaliplatin. Foods. 12:17332023. View Article : Google Scholar : PubMed/NCBI
|
|
219
|
Kottakis G, Kambouri K, Giatromanolaki A,
Valsami G, Kostomitsopoulos N, Tsaroucha A and Pitiakoudis M:
Effects of the antioxidant quercetin in an experimental model of
ulcerative colitis in mice. Medicina (Kaunas). 59:872022.
View Article : Google Scholar : PubMed/NCBI
|
|
220
|
Li Y, Xu Z, Zhao S, Huang T, Xu J, Wang S,
Sang Y, Yu W and Wang X: Oral administration of curcumin and
quercetin nanoparticles can improve ulcerative colitis by
regulating intestinal microorganisms. Front Nutr. 12:16966992025.
View Article : Google Scholar : PubMed/NCBI
|
|
221
|
Wei Q, Jiang H, Zeng J, Xu J, Zhang H,
Xiao E, Lu Q and Huang G: Quercetin protected the gut barrier in
ulcerative colitis by activating aryl hydrocarbon receptor.
Phytomedicine. 140:1566332025. View Article : Google Scholar : PubMed/NCBI
|
|
222
|
Li J, Yan Y and Chen F: Clinical trial
landscape for histone deacetylation inhibitors in breast cancer: A
dawn in the darkness? J Transl Med. 22:10812024. View Article : Google Scholar : PubMed/NCBI
|
|
223
|
Tan LLY, Le QT, Lee NYY and Chua MLK:
JUPITER-02 trial: Advancing survival for recurrent metastatic
nasopharyngeal carcinoma and next steps. Cancer Commun (Lond).
42:56–59. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
224
|
Zhu D, Wang Z, Zhang G, Ma C, Qiu X, Wang
Y, Liu M, Guo X, Chen H, Deng Q and Kang X: Periostin promotes
nucleus pulposus cells apoptosis by activating the Wnt/β-catenin
signaling pathway. FASEB J. 36:e223692022. View Article : Google Scholar : PubMed/NCBI
|
|
225
|
Takashima K, Okano H, Ojiro R, Tang Q,
Takahashi Y, Ozawa S, Zou X, Koyanagi M, Maronpot RR, Yoshida T and
Shibutani M: Continuous exposure to alpha-glycosyl isoquercitrin
from gestation ameliorates disrupted hippocampal neurogenesis in
rats induced by gestational injection of valproic acid. Neurotox
Res. 40:2278–2296. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
226
|
Takashima K, Okano H, Ojiro R, Tang Q,
Takahashi Y, Ozawa S, Zou X, Koyanagi M, Maronpot RR, Yoshida T and
Shibutani M: Continuous exposure to alpha-glycosyl isoquercitrin
from mid-gestation ameliorates polyinosinic-polycytidylic
acid-disrupted hippocampal neurogenesis in rats. J Chem Neuroanat.
128:1022192023. View Article : Google Scholar : PubMed/NCBI
|
|
227
|
Huang S, Cao B, Zhang J, Feng Y, Wang L,
Chen X, Su H, Liao S, Liu J, Yan J and Liang B: Induction of
ferroptosis in human nasopharyngeal cancer cells by cucurbitacin B:
Molecular mechanism and therapeutic potential. Cell Death Dis.
12:2372021. View Article : Google Scholar : PubMed/NCBI
|
|
228
|
Li Y, Chen F, Chen J, Chan S, He Y, Liu W
and Zhang G: Disulfiram/copper induces antitumor activity against
both nasopharyngeal cancer cells and cancer-associated fibroblasts
through ROS/MAPK and ferroptosis pathways. Cancers (Basel).
12:1382020. View Article : Google Scholar : PubMed/NCBI
|
|
229
|
Chen C, Nie D, Huang Y, Yu X, Chen Z,
Zhong M, Liu X, Wang X, Sui S, Liu Z, et al: Anticancer effects of
disulfiram in T-cell malignancies through NPL4-mediated
ubiquitin-proteasome pathway. J Leukoc Biol. 112:919–929. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
230
|
Serra R, Zhao T, Huq S, Gorelick NL,
Casaos J, Cecia A, Mangraviti A, Bai R, Olivi A, Brem H, et al:
Disulfiram and copper combination therapy targets NPL4, cancer stem
cells and prolongs survival in group 3 medulloblastoma.
Neurosurgery. 87 (Suppl 1):S9082020.
|
|
231
|
Serra R, Zhao T, Huq S, Gorelick NL,
Casaos J, Cecia A, Mangraviti A, Eberhart C, Bai R, Olivi A, et al:
Disulfiram and copper combination therapy targets NPL4, cancer stem
cells and extends survival in a medulloblastoma model. PLoS One.
16:e02519572021. View Article : Google Scholar : PubMed/NCBI
|
|
232
|
Lian Q, Chen F, Sha Z, Zhao H, Li J, Chen
T, Liu C, Wang B, Wang Z and Qiao S: Disulfiram upgrades the
radiosensitivity of osteosarcoma by enhancing apoptosis and
P53-induced cell cycle arrest. Radiat Res. 202:752–764. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
233
|
Wu X, Xue X, Wang L, Wang W, Han J, Sun X,
Zhang H, Liu Y, Che X, Yang J and Wu C: Suppressing autophagy
enhances disulfiram/copper-induced apoptosis in non-small cell lung
cancer. Eur J Pharmacol. 827:1–12. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
234
|
Wang K, Michelakos T, Wang B, Shang Z,
DeLeo AB, Duan Z, Hornicek FJ, Schwab JH and Wang X: Targeting
cancer stem cells by disulfiram and copper sensitizes
radioresistant chondrosarcoma to radiation. Cancer Lett. 505:37–48.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
235
|
Park YM, Kim DH, Kang MS, Koh YW, Choi EC
and Kim SH: Abstract B25: Anticancer effects of disulfiram in head
and neck squamous cell carcinoma via autophagic cell death. Clin
Cancer Res. 26 (12 Suppl 2):B252020. View Article : Google Scholar
|
|
236
|
Li Z, Cao S, Sun Y, Niu Z, Liu X, Niu J
and Zhou Y: TIPE3 is a candidate prognostic biomarker promoting
tumor progression via elevating RAC1 in pancreatic cancer. Mol
Cancer. 21:1602022. View Article : Google Scholar : PubMed/NCBI
|
|
237
|
Li Z, Cao S, Sun Y, Niu Z, Liu X, Niu J,
PavelM A, Sridhar A, Maienschein-Cline M, Ong SG, et al:
Late-breaking basic science abstracts from the american heart
association's scientific sessions 2021. Circ Res. Dec 2–2021.(Epub
ahead of print).
|
|
238
|
Guo J, Ma Y, Tang T, Bian Z, Li Q, Tang L,
Li Z, Li M, Wang L, Zeng A, et al: Modulation of immune-responses
by DSF/Cu enhances the anti-tumor effects of DTX for metastasis
breast cancer. J Cancer. 15:1523–1535. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
239
|
Ghaffarianhoseini A, Ghaffarianhoseini A,
Berardi U, Tookey J, Li DHW and Kariminia S: Exploring the
advantages and challenges of double-skin façades (DSFs). Renew
Sustain Energy Rev. 60:1052–1065. 2016. View Article : Google Scholar
|
|
240
|
Zhu Y, Lei C, Jiang Q, Yu Q and Qiu L:
DSF/Cu induces antitumor effect against diffuse large B-cell
lymphoma through suppressing NF-κB/BCL6 pathways. Cancer Cell Int.
22:2362022. View Article : Google Scholar : PubMed/NCBI
|
|
241
|
Waldron EJ, Snyder D, Fernandez NL, Sileo
E, Inoyama D, Freundlich JS, Waters CM, Cooper VS and Neiditch MB:
Structural basis of DSF recognition by its receptor RpfR and its
regulatory interaction with the DSF synthase RpfF. PLoS Biol.
17:e30001232019. View Article : Google Scholar : PubMed/NCBI
|
|
242
|
Gennaro G, Catto Lucchino E, Goia F and
Favoino F: Modelling double skin façades (DSFs) in whole-building
energy simulation tools: Validation and inter-software comparison
of naturally ventilated single-story DSFs. Build Environ.
231:1100022023. View Article : Google Scholar
|
|
243
|
Catto Lucchino E, Gelesz A, Skeie K,
Gennaro G, Reith A, Serra V and Goia F: Modelling double skin
façades (DSFs) in whole-building energy simulation tools:
Validation and inter-software comparison of a mechanically
ventilated single-story DSF. Build Environ. 199:1079062021.
View Article : Google Scholar
|
|
244
|
Rempfer C, Hoernstein SNW, van Gessel N,
Graf AW, Spiegelhalder RP, Bertolini A, Bohlender LL, Parsons J,
Decker EL and Reski R: Differential prolyl hydroxylation by six
Physcomitrella prolyl-4 hydroxylases. bioRxiv. 2024.
|
|
245
|
Rempfer C, Hoernstein SNW, van Gessel N,
Graf AW, Spiegelhalder RP, Bertolini A, Bohlender LL, Parsons J,
Decker EL and Reski R: Differential prolyl hydroxylation by six
Physcomitrella prolyl-4 hydroxylases. Comput Struct Biotechnol J.
23:2580–2594. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
246
|
McKenzie AJ, Hoshino D, Hong NH, Cha DJ,
Franklin JL, Coffey RJ, Patton JG and Weaver AM: KRAS-MEK signaling
controls Ago2 sorting into exosomes. Cell Rep. 15:978–987. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
247
|
Hu P, Zhao H, Zhu P, Xiao Y, Miao W, Wang
Y and Jin H: Dual regulation of Arabidopsis AGO2 by arginine
methylation. Nat Commun. 10:8442019. View Article : Google Scholar : PubMed/NCBI
|
|
248
|
Zhou R, Qiu L, Zhou L, Geng R, Yang S and
Wu J: P4HA1 activates HMGCS1 to promote nasopharyngeal carcinoma
ferroptosis resistance and progression. Cell Signal.
105:1106092023. View Article : Google Scholar : PubMed/NCBI
|
|
249
|
Meng Y, Sun HY, He Y, Zhou Q, Liu YH, Su
H, Yin MZ, Zeng FR, Chen X and Deng GT: BET inhibitors potentiate
melanoma ferroptosis and immunotherapy through AKR1C2 inhibition.
Mil Med Res. 10:612023.PubMed/NCBI
|
|
250
|
Li Q and Gan B: Uncovering the
IL-1β-PCAF-NNT axis: A new player in ferroptosis and tumor immune
evasion. Cancer Commun (Lond). 43:1048–1050. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
251
|
Qiu L, Zhou R, Zhou L, Yang S and Wu J:
CAPRIN2 upregulation by LINC00941 promotes nasopharyngeal carcinoma
ferroptosis resistance and metastatic colonization through HMGCR.
Front Oncol 6. 12:9317492022. View Article : Google Scholar : PubMed/NCBI
|
|
252
|
Ning Y, Zheng H, Zhan Y, Liu S, Yang Y,
Zang H, Wen Q, Zhang Y and Fan S: Overexpression of P4HA1
associates with poor prognosis and promotes cell proliferation and
metastasis of lung adenocarcinoma. J Cancer. 12:6685–6694. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
253
|
Robinson AD, Chakravarthi BVSK, Agarwal S,
Chandrashekar DS, Davenport ML, Chen G, Manne U, Beer DG, Edmonds
MD and Varambally S: Collagen modifying enzyme P4HA1 is
overexpressed and plays a role in lung adenocarcinoma. Transl
Oncol. 14:1011282021. View Article : Google Scholar : PubMed/NCBI
|
|
254
|
Navarro-Serer B, Wissler MF, Glover BK,
Lerner MG, Oza HH, Wang V, Knutsdottir H, Shojaeian F, Noller K,
Baskaran SG, et al: P4HA1 mediates hypoxia-induced invasion in
human pancreatic cancer organoids. Cancer Res Commun. 5:881–895.
2025. View Article : Google Scholar : PubMed/NCBI
|
|
255
|
Hu T, Gou W, Ren Z, Liu G, Li Y, Zuo D and
Hou W: Icaritin increases radiosensitivity of nasopharyngeal
carcinoma cells by regulating iron death. Nan Fang Yi Ke Da Xue Xue
Bao. 43:1665–1673. 2023.(In Chinese). PubMed/NCBI
|
|
256
|
Zhang D, Wu X, Xue X, Li W, Zhou P, Lv Z,
Zhao K and Zhu F: Ancient dormant virus remnant ERVW-1 drives
ferroptosis via degradation of GPX4 and SLC3A2 in schizophrenia.
Virol Sin. 39:31–43. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
257
|
Chen H, Li Y, Deng C, Liang X and Liu G:
O-254 ACTRT2 deficiency increases spermatogonia vulnerability to
ferroptosis. Hum Reprod. 38:dead093.308. 2023. View Article : Google Scholar
|
|
258
|
Qin J, Chen Z, Ye M, Liang L and Ding X:
High glucose promotes O-GlcNAcylation of ACSL4 to induce
ferroptosis of renal tubular epithelial cell. Autoimmunity.
58:25768812025. View Article : Google Scholar : PubMed/NCBI
|
|
259
|
Zhou R, Wang X, Jin Y, Chen B, Liu H, Zhao
X, Jing D and Zhao B: Mechanism of lidocaine-induced ROS generation
triggering DNA double-strand breaks and promoting intervertebral
disc cell senescence via the MYC-DUSP1-P53 axis. Free Radic Biol
Med. 240:457–471. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
260
|
Yue C, Qian Y, Wang C, Chen J, Wang J,
Wang Z, Wan X, Cao S, Zhu J, Tao Q, et al: TRIM29 acts as a
potential senescence suppressor with epigenetic activation in
nasopharyngeal carcinoma. Cancer Sci. 114:3176–3189. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
261
|
Srinivas US, Tan BWQ, Vellayappan BA and
Jeyasekharan AD: ROS and the DNA damage response in cancer. Redox
Biol. 25:1010842019. View Article : Google Scholar : PubMed/NCBI
|
|
262
|
Ding Y, Xiu H, Zhang Y, Ke M, Lin L, Yan
H, Hu P, Xiao M, He X and Zhang T: Learning and investigation of
the role of angiotensin-converting enzyme in radiotherapy for
nasopharyngeal carcinoma. Biomedicines. 11:15812023. View Article : Google Scholar : PubMed/NCBI
|
|
263
|
Wang SY, Xu XW, Yao JJ, Peng PJ, Zhou B,
Liu QD, Huang XP and Lin Z: Dose escalation of lobaplatin
concurrent with IMRT for the treatment of stage III–IVb NPC: A
phase I clinical trial. Transl Oncol. 11:1007–1011. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
264
|
Tang Q, Mei C, Huang B, Huang R, Kang L,
Chen A, Lei N, Deng P, Ying S, Zhang P and Qin Y: Risk
stratification of LA-NPC during chemoradiotherapy based on clinical
classification and TVRR. Cancer Med. 13:e70292024. View Article : Google Scholar : PubMed/NCBI
|
|
265
|
Kim KY, Le QT, Yom SS, Ng RHW, Chan KCA,
Bratman SV, Welch JJ, Divi RL, Petryshyn RA and Conley BA: Clinical
utility of Epstein-Barr virus DNA testing in the treatment of
nasopharyngeal carcinoma patients. Int J Radiat Oncol Biol Phys.
98:996–1001. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
266
|
He Q, Tuo Y, Zhou Y, Yan Y, Liu X, Zhao D,
Wang Q, Luo H, Zhang Z, Meng F, et al: MB based RT-qPCR increase
the clinical application of cfEBV DNA for NPC in non-endemic area
of China. Sci Rep. 15:91862025. View Article : Google Scholar : PubMed/NCBI
|
|
267
|
Burton BK, Ellis AG, Orr B, Chatlani S,
Yoon K, Shoaff JR and Gallo D: Estimating the prevalence of
Niemann-Pick disease type C (NPC) in the United States. Mol Genet
Metab. 134:182–187. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
268
|
Wang MD, Li HT, Peng LX, Mei Y, Zheng LS,
Li CZ, Meng DF, Lang YH, Xu L, Peng XS, et al: TSPAN1 inhibits
metastasis of nasopharyngeal carcinoma via suppressing NF-kB
signaling. Cancer Gene Ther. 31:454–463. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
269
|
Zhang X, Qian S, Wu P, Yu B, Yin D, Peng
X, Li S, Xiao Z and Xie Z: Tumor-associated macrophage-derived
itaconic acid contributes to nasopharyngeal carcinoma progression
by promoting immune escape via TET2. Cell Commun Signal.
22:4132024. View Article : Google Scholar : PubMed/NCBI
|
|
270
|
Zhang X, Song X, Lai Y, Zhu B, Luo J, Yu H
and Yu Y: Identification of key pseudogenes in nasopharyngeal
carcinoma based on RNA-Seq analysis. BMC Cancer. 21:4832021.
View Article : Google Scholar : PubMed/NCBI
|
|
271
|
Renaud S, Lefebvre A, Mordon S, Moralès O
and Delhem N: Novel therapies boosting T cell immunity in epstein
barr virus-associated nasopharyngeal carcinoma. Int J Mol Sci.
21:42922020. View Article : Google Scholar : PubMed/NCBI
|
|
272
|
Cheu JWS, Lee D, Li Q, Goh CC, Bao MHR,
Yuen VWH, Zhang MS, Yang C, Chan CY, Tse AP, et al: Ferroptosis
suppressor protein 1 inhibition promotes tumor ferroptosis and
anti-tumor immune responses in liver cancer. Cell Mol Gastroenterol
Hepatol. 16:133–159. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
273
|
Cui K, Wang K and Huang Z: Ferroptosis and
the tumor microenvironment. J Exp Clin Cancer Res. 43:3152024.
View Article : Google Scholar : PubMed/NCBI
|
|
274
|
Kojima Y, Tanaka M, Sasaki M, Ozeki K,
Shimura T, Kubota E and Kataoka H: Induction of ferroptosis by
photodynamic therapy and enhancement of antitumor effect with
ferroptosis inducers. J Gastroenterol. 59:81–94. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
275
|
Cai W, Wu S, Lin Z, Ming X, Yang X, Yang M
and Chen X: Hypoxia-induced BAP1 enhances erastin-induced
ferroptosis in nasopharyngeal carcinoma by stabilizing H2A. Cancer
Cell Int. 24:3072024. View Article : Google Scholar : PubMed/NCBI
|
|
276
|
Chen W, Zuo F, Zhang K, Xia T, Lei W,
Zhang Z, Bao L and You Y: Exosomal MIF derived from nasopharyngeal
carcinoma promotes metastasis by repressing ferroptosis of
macrophages. Front Cell Dev Biol. 9:7911872021. View Article : Google Scholar : PubMed/NCBI
|
|
277
|
Chen X, Wang X, Zou Y, Wang Y, Duan T,
Zhou Z, Huang Y and Ye Q: EMC2 suppresses ferroptosis via
regulating TFRC in nasopharyngeal carcinoma. Transl Oncol.
52:1022512025. View Article : Google Scholar : PubMed/NCBI
|
|
278
|
Zheng D, Chu T, Yang D, Liang S, Yang L,
Yang Y, Zhang K and Ma W: Targeting ferroptosis in nasopharyngeal
carcinoma: Mechanisms of therapy resistance and therapeutic
opportunities. Adv Biol (Weinh). Oct 30–2025.(Epub ahead of print).
View Article : Google Scholar
|
|
279
|
Liang Z, Zhao W, Li X, Wang L, Meng L and
Yu R: Cisplatin synergizes with PRLX93936 to induce ferroptosis in
non-small cell lung cancer cells. Biochem Biophys Res Commun.
569:79–85. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
280
|
Roh JL, Kim EH, Jang H and Shin D: Nrf2
inhibition reverses the resistance of cisplatin-resistant head and
neck cancer cells to artesunate-induced ferroptosis. Redox Biol.
11:254–262. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
281
|
Takahashi R, Kamizaki K, Yamanaka K, Terai
Y and Minami Y: Expression of Ferredoxin1 in cisplatin-resistant
ovarian cancer cells confers their resistance against ferroptosis
induced by cisplatin. Oncol Rep. 49:1242023. View Article : Google Scholar : PubMed/NCBI
|
|
282
|
Perera L, Brown SM, Silver BB, Tokar EJ
and Sinha BK: Ferroptosis inducers erastin and RSL3 enhance
adriamycin and topotecan sensitivity in ABCB1/ABCG2-expressing
tumor cells. Int J Mol Sci. 26:6352025. View Article : Google Scholar : PubMed/NCBI
|
|
283
|
Bao C, Liu C, Liu Q, Hua L, Hu J, Li Z and
Xu S: Liproxstatin-1 alleviates LPS/IL-13-induced bronchial
epithelial cell injury and neutrophilic asthma in mice by
inhibiting ferroptosis. Int Immunopharmacol. 109:1087702022.
View Article : Google Scholar : PubMed/NCBI
|
|
284
|
Zhang B, Chen X, Ru F, Gan Y, Li B, Xia W,
Dai G, He Y and Chen Z: Liproxstatin-1 attenuates unilateral
ureteral obstruction-induced renal fibrosis by inhibiting renal
tubular epithelial cells ferroptosis. Cell Death Dis. 12:8432021.
View Article : Google Scholar : PubMed/NCBI
|
|
285
|
Cui J, Chen Y, Yang Q, Zhao P, Yang M,
Wang X, Mang G, Yan X, Wang D, Tong Z, et al: Protosappanin A
protects DOX-induced myocardial injury and cardiac dysfunction by
targeting ACSL4/FTH1 axis-dependent ferroptosis. Adv Sci (Weinh).
11:e23102272024. View Article : Google Scholar : PubMed/NCBI
|
